0,976  0,003  Antineoplastic (lung cancer)
0,930  0,004  Antineoplastic (breast cancer)
0,913  0,004  Antineoplastic (colorectal cancer)
0,911  0,003  Antineoplastic (cervical cancer)
0,912  0,004  Antineoplastic (colon cancer)
0,895  0,002  Topoisomerase II inhibitor
0,895  0,006  Apoptosis agonist
0,885  0,003  Antineoplastic (carcinoma)
0,881  0,003  Tubulin antagonist
0,876  0,003  DNA damaging
0,875  0,004  Prostate cancer treatment
0,873  0,005  Antileukemic
0,868  0,004  Antineoplastic (non-small cell lung cancer)
0,866  0,004  Antineoplastic (ovarian cancer)
0,862  0,004  Cytostatic
0,858  0,004  Antineoplastic (lymphocytic leukemia)
0,855  0,003  Antineoplastic (squamous cell carcinoma)
0,848  0,003  Caspase 3 stimulant
0,846  0,003  Antimitotic
0,806  0,005  Antineoplastic (melanoma)
0,745  0,002  Carcinogenic, group 1
0,749  0,018  Caspase 9 stimulant
0,734  0,004  Antineoplastic (brain cancer)
0,723  0,002  Topoisomerase II alpha inhibitor
0,723  0,004  Genotoxic
0,732  0,015  CYP3A4 substrate
0,718  0,004  Antineoplastic (multiple myeloma)
0,714  0,004  Antineoplastic (renal cancer)
0,714  0,005  Antineoplastic (glioma)
0,721  0,018  Transcription factor NF kappa B inhibitor
0,704  0,003  Alpha tubulin antagonist
0,696  0,004  Antineoplastic (glioblastoma multiforme)
0,682  0,003  Antineoplastic (small cell lung cancer)
0,676  0,004  DNA intercalator
0,675  0,004  Antineoplastic (lymphoma)
0,671  0,011  Antineoplastic (solid tumors)
0,638  0,004  Hepatoprotectant
0,630  0,003  Topoisomerase I inhibitor
0,612  0,002  Carcinogenic, group 2A
0,597  0,006  Antineoplastic (osteosarcoma)
0,595  0,008  Hypoxia-inducible factor 1 alpha inhibitor
0,582  0,004  Alkylator
0,577  0,004  Beta tubulin antagonist
0,582  0,009  Antipyretic
0,576  0,005  Antineoplastic (sarcoma)
0,573  0,014  Hepatic disorders treatment
0,538  0,002  Keratolytic
0,547  0,014  CYP2C19 inhibitor
0,525  0,010  CYP3A4 inhibitor
0,513  0,004  Antineoplastic (bone cancer)
0,527  0,023  CYP2C19 substrate
0,509  0,023  Cytotoxic
0,500  0,024  CYP1A2 substrate
0,485  0,009  P-glycoprotein inhibitor
0,472  0,022  NOS2 expression inhibitor
0,469  0,022  Chemopreventive
0,446  0,016  Antineoplastic (liver cancer)
0,462  0,034  5 Hydroxytryptamine release stimulant
0,448  0,024  Vasodilator, coronary
0,427  0,018  Antineoplastic (endocrine cancer)
0,454  0,046  Immunosuppressant
0,430  0,029  ICAM1 expression inhibitor
0,436  0,037  Antihypercholesterolemic
0,409  0,036  Antineoplastic (pancreatic cancer)
0,413  0,042  Respiratory analeptic
0,362  0,002  Topoisomerase II beta inhibitor
0,405  0,046  Antineoplastic (non-Hodgkin's lymphoma)
0,381  0,036  Sensitization
0,351  0,009  Neurotrophic factor enhancer
0,411  0,074  TNF expression inhibitor
0,341  0,016  VCAM1 expression inhibitor
0,340  0,020  Antiviral (Herpes)
0,327  0,011  Cyclooxygenase 1 inhibitor
0,353  0,039  Radiosensitizer
0,342  0,033  Nitric oxide antagonist
0,371  0,073  Ulceration
0,295  0,002  Microtubule formation inhibitor
0,327  0,045  Proliferative diseases treatment
0,298  0,022  Melanin inhibitor
0,327  0,054  Embryotoxic
0,305  0,044  Carcinogenic
0,285  0,038  Abortion inducer
0,250  0,005  Antineoplastic alkaloid
0,313  0,068  Analeptic
0,252  0,025  Liver fibrosis treatment
0,265  0,048  Antiparkinsonian, rigidity relieving
0,243  0,028  Protein kinase stimulant
0,327  0,113  15-Lipoxygenase inhibitor
0,293  0,085  CYP2D6 substrate
0,276  0,071  Antioxidant
0,273  0,069  Antiprotozoal (Trypanosoma)
0,256  0,056  Psychostimulant
0,269  0,071  Teratogen
0,277  0,080  Spasmolytic
0,286  0,091  AR expression inhibitor
0,235  0,049  Glyceraldehyde-3-phosphate dehydrogenase inhibitor
0,216  0,038  Contraceptive
0,189  0,011  DNA repair enzyme inhibitor
0,215  0,042  LDLR expression enhancer
0,245  0,072  Vasodilator
0,241  0,072  Cardiodepressant
0,286  0,118  CYP2C9 substrate
0,182  0,016  Calcium antagonist
0,173  0,007  Ornithine decarboxylase inhibitor
0,209  0,051  Muscle relaxant
0,219  0,062  Mutagenic
0,285  0,131  Antineoplastic (myeloid leukemia)
0,179  0,028  Cyclooxygenase 3 inhibitor
0,202  0,055  Lipocortins synthesis antagonist
0,156  0,010  Antiprotozoal activity enhancer
0,229  0,084  DNA synthesis inhibitor
0,181  0,037  Cyclooxygenase 2 inhibitor
0,216  0,073  Pyruvate kinase inhibitor
0,187  0,047  Cyclooxygenase inhibitor
0,152  0,018  CDC-like kinase 3 inhibitor
0,263  0,132  Calcium channel activator
0,234  0,103  UGT2B4 substrate
0,137  0,011  ATPase (Vacuolar H+) inhibitor
0,179  0,058  ATPase inhibitor
0,163  0,043  Adenylate cyclase stimulant
0,166  0,048  Antifungal enhancer
0,223  0,106  Antineoplastic (bladder cancer)
0,116  0,015  Postmenopausal disorders treatment
0,226  0,125  CYP2D6 inhibitor
0,196  0,101  Free radical scavenger
0,193  0,099  Cyclic AMP phosphodiesterase inhibitor
0,096  0,011  Nitric oxide donor
0,168  0,083  Antineoplastic (gastric cancer)
0,181  0,097  Antihypertriglyceridemic
0,095  0,012  Hypercalcemia treatment
0,108  0,032  Dual specificity tyrosine-phosphorylation regulated kinase 2 inhibitor
0,078  0,006  Endothelin receptor antagonist
0,123  0,052  Mucolytic
0,222  0,152  Vasodilator, peripheral
0,208  0,141  NOS3 expression inhibitor
0,140  0,075  Skeletal muscle relaxant
0,114  0,055  Expectorant
0,063  0,005  Endothelin B receptor antagonist
0,169  0,111  Pneumotoxic
0,120  0,065  Alcohol dehydrogenase substrate
0,100  0,046  Antineoplastic antibiotic
0,105  0,055  Anabolic
0,065  0,018  Potassium channel Kv1.3 blocker
0,144  0,099  Interleukin 6 antagonist
0,051  0,006  Endothelin A receptor antagonist
0,121  0,082  Antineoplastic (uterine cancer)
0,115  0,079  Contraceptive female
0,055  0,021  Microtubule stabilization
0,071  0,040  Exportin-1 inhibitor
0,122  0,092  Lipid peroxidase inhibitor
0,133  0,104  Ca2+-transporting ATPase inhibitor
0,146  0,120  Non-steroidal antiinflammatory agent
0,146  0,124  UGT1A1 substrate
0,118  0,096  Antiparkinsonian, tremor relieving
0,138  0,120  Platelet adhesion inhibitor
0,084  0,067  Sodium/hydrogen exchanger 5 inhibitor
0,059  0,042  HIV-1 integrase (Strand Transfer) inhibitor
0,146  0,129  Phobic disorders treatment
0,051  0,035  Estrogen agonist
0,050  0,034  Factor III inhibitor
0,139  0,124  UGT2B10 substrate
0,190  0,174  Cholesterol antagonist
0,066  0,051  Glutamate (mGluR7) antagonist
0,074  0,060  Antitreponemal
0,131  0,116  Prostate disorders treatment
0,102  0,093  Estrogen antagonist
0,056  0,049  Ryanodine receptor antagonist
0,067  0,063  Na+ K+ transporting ATPase inhibitor
0,052  0,050  Acetyl-CoA transferase 2 inhibitor
0,109  0,108  CDC-like kinase 1 inhibitor
0,054  0,053  Lipocortins synthesis agonist

